{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:44:24Z","timestamp":1785757464795,"version":"3.56.0"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Endothelins are a family of vasoconstrictive peptides known\nfor their high potency. They are mainly synthesized and secreted by the endothelial cells\nlining the blood vessels in response to various stimuli. Their main physiological role is\nthe regulation of vascular tone, affecting blood pressure and tissue perfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The aim of this review was to evaluate the importance of Endothelin-1\n(ET-1) plasma levels as a marker in diagnosis, disease burden, or development, due to\nits vascular effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data from several studies in different organ systems, collected over the last\nthirty years, were collected. A statistical analysis was performed to reveal any similarities\nand differences among them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ET-1 was found to be increased in arterial and pulmonary hypertension. Plasma\nET-1 was elevated in patients with heart failure, autoimmune disease, chronic kidney disease,\nand liver failure. In all these cases, ET-1 was increased at least twice the maximum\nof normal plasma concentration in healthy subjects, in a similar pattern, independently\nof the disease background. More importantly, plasma ET-I levels increased even more\naccording to the severity of the disease, not necessarily in a linear manner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Plasma ET-1 levels appears to increase whenever a disorder or dysfunction\noccurs in kidney, heart, lungs, liver and pancreas. Since, remission is followed by a reduction\nin the already elevated levels, plasma ET-1 emerges to be an important diagnostic\nmolecule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Endothelin-1 appears to increase similarly across various pathological conditions,\nmaking it a potential biomarker for overall human physiological status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673377544250714073536","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:53:46Z","timestamp":1759312426000},"page":"2909-2924","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endothelin: A Potential Universal Systemic Biomarker"],"prefix":"10.2174","volume":"33","author":[{"given":"Evangelia","family":"Zacharioudaki","sequence":"first","affiliation":[{"name":"Laboratory of Biology, Department of Biology, University of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella","family":"Trivyza","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-989X","authenticated-orcid":true,"given":"Marios","family":"Papasotiriou","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2705-225X","authenticated-orcid":true,"given":"Sotiris","family":"Tsakas","sequence":"additional","affiliation":[{"name":"Laboratory of Biology, Department of Biology, University of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"Furchgott R.F.","year":"1980","unstructured":"Furchgott R.F.; Zawadzki J.V.; The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature  1980,288(5789),373-376","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"Yanagisawa M.","year":"1988","unstructured":"Yanagisawa M.; Kurihara H.; Kimura S.; Tomobe Y.; Kobayashi M.; Mitsui Y.; Yazaki Y.; Goto K.; Masaki T.; A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature  1988,332(6163),411-415","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/0165-6147(89)90011-4","volume":"10","author":"Masashi Y.","year":"1989","unstructured":"Masashi Y.; Tomoh M.; Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci  1989,10(9),374-378","journal-title":"Trends Pharmacol Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/B978-0-12-385095-9.00070-1","author":"Haque S.","year":"2013","unstructured":"Haque S.; Welch H.; Loizidou M.;  Handbook of biologically active peptides  2013,512-518","journal-title":"Handbook of biologically active peptides"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/biology11050759","volume":"11","author":"Haryono A.","year":"2022","unstructured":"Haryono A.; Ramadhiani R.; Ryanto G.R.T.; Emoto N.; Endothelin and the cardiovascular system: The long journey and where we are going. Biology  2022,11(5),759","journal-title":"Biology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/ki.2014.143","volume":"86","author":"Kohan D.E.","year":"2014","unstructured":"Kohan D.E.; Barton M.; Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int  2014,86(5),896-904","journal-title":"Kidney Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.123.21716","volume":"81","author":"Schiffrin E. L.","year":"2024","unstructured":"Schiffrin E. L.; Pollock D. M.; Endothelin system in hypertension and chronic kidney disease. Hypertension  2024,81(4),691-701","journal-title":"Hypertension"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"CD004434","DOI":"10.1002\/14651858.CD004434.pub6","volume":"2021","author":"Liu C.","year":"2021","unstructured":"Liu C.; Chen J.; Gao Y.; Deng B.; Liu K.; Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Libr  2021,2021(3),CD004434","journal-title":"Cochrane Libr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","volume":"74","author":"Barton M.","year":"2019","unstructured":"Barton M.; Yanagisawa M.; Endothelin: 30 Years from discovery to therapy. Hypertension  2019,74(6),1232-1265","journal-title":"Hypertension"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.3390\/ijms241411295","volume":"24","author":"Banecki K.M.R.M.","year":"2023","unstructured":"Banecki K.M.R.M.; Dora K.A.; Endothelin-1 in health and disease. Int J Mol Sci  2023,24(14),11295","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.1097\/00005344-199100177-00115","volume":"17","author":"Miyamori I.","year":"1991","unstructured":"Miyamori I.; Takeda Y.; Yoneda T.; Takeda R.; Endothelin-1 release from mesenteric arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol  1991,17(Suppl. 7),S408-S410","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.HYP.21.3.294","volume":"21","author":"Larivi\u00e8re R.","year":"1993","unstructured":"Larivi\u00e8re R.; Thibault G.; Schiffrin E.L.; Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension  1993,21(3),294-300","journal-title":"Hypertension"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.RES.76.5.767","volume":"76","author":"T\u00f8nnessen T.","year":"1995","unstructured":"T\u00f8nnessen T.; Giaid A.; Saleh D.; Naess P.A.; Yanagisawa M.; Christensen G.; Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res  1995,76(5),767-772","journal-title":"Circ Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00041552-199401000-00012","volume":"3","author":"Nassar G.M.","year":"1994","unstructured":"Nassar G.M.; Badr K.F.; Endothelin in kidney diseases. Curr Opin Nephrol Hypertens  1994,3(1),86-91","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/ndt\/12.3.470","volume":"12","author":"Vlachojannis J.","year":"1997","unstructured":"Vlachojannis J.; Tsakas S.; Petropoulou C.; Kurz P.; Increased renal excretion of endothelin-1 in nephrotic patients. Nephrol Dial Transplant  1997,12(3),470-473","journal-title":"Nephrol Dial Transplant"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0024-3205(97)00105-7","volume":"61","author":"Ito H.","year":"1997","unstructured":"Ito H.; Endothelins and cardiac hypertrophy. Life Sci  1997,61(6),585-593","journal-title":"Life Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","volume":"30","author":"Jankowich M.","year":"2020","unstructured":"Jankowich M.; Choudhary G.; Endothelin-1 levels and cardiovascular events. Trends Cardiovasc Med  2020,30(1),1-8","journal-title":"Trends Cardiovasc Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yjmcc.2022.03.007","volume":"167","author":"Abraham G.R.","year":"2022","unstructured":"Abraham G.R.; Kuc R.E.; Althage M.; Greasley P.J.; Ambery P.; Maguire J.J.; Wilkinson I.B.; Hoole S.P.; Cheriyan J.; Davenport A.P.; Endothelin-1 is increased in the plasma of patients hospitalised with COVID-19. J Mol Cell Cardiol  2022,167,92-96","journal-title":"J Mol Cell Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0168-8278(05)80584-7","volume":"19","author":"M\u00f8ller S.","year":"1993","unstructured":"M\u00f8ller S.; Emmeluth C.; Henriksen J.H.; Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J Hepatol  1993,19(2),285-290","journal-title":"J Hepatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jcla.2","volume":"15","author":"Chen H.C.","year":"2001","unstructured":"Chen H.C.; Guh J.Y.; Chang J.M.; Tsai J.C.; Hwang S.J.; Lai Y.H.; Plasma and urinary endothelin-1 in focal segmental glomerulosclerosis. J Clin Lab Anal  2001,15(2),59-63","journal-title":"J Clin Lab Anal"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2004.09.010","volume":"104","author":"Yeh J.L.","year":"2005","unstructured":"Yeh J.L.; Hsu J.H.; Dai Z.K.; Liou S.F.; Chen I.J.; Wu J.R.; Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease. Int J Cardiol  2005,104(1),15-20","journal-title":"Int J Cardiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.lfs.2012.02.013","volume":"91","author":"Cellini M.","year":"2012","unstructured":"Cellini M.; Strobbe E.; Gizzi C.; Balducci N.; Toschi P.G.; Campos E.C.; Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. Life Sci  2012,91(13-14),699-702","journal-title":"Life Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2014.12.061","volume":"239","author":"Bossard M.","year":"2015","unstructured":"Bossard M.; Pumpol K.; van der Lely S.; Aeschbacher S.; Schoen T.; Krisai P.; Lam T.; Todd J.; Estis J.; Risch M.; Risch L.; Conen D.; Plasma endothelin-1 and cardiovascular risk among young and healthy adults. Atherosclerosis  2015,239(1),186-191","journal-title":"Atherosclerosis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e1712","DOI":"10.1097\/MD.0000000000001712","volume":"94","author":"Gu X.","year":"2015","unstructured":"Gu X.; Li H.; Zhu X.; Gu H.; Chen J.; Wang L.; Harding P.; Xu W.; Inverse correlation between plasma adropin and et-1 levels in essential hypertension: A cross- sectional study. Medicine  2015,94(40),e1712","journal-title":"Medicine"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e0208206","DOI":"10.1371\/journal.pone.0208206","volume":"13","author":"Mayyas F.","year":"2018","unstructured":"Mayyas F.; Saadeh N.; Al-Muqbel K.; Van Wagoner D.R.; Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism. PLoS One  2018,13(12),e0208206","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/pathophysiology28040031","volume":"28","author":"Kostov K.","year":"2021","unstructured":"Kostov K.; Blazhev A.; Circulating levels of endothelin-1 and big endothelin-1 in patients with essential hypertension. Pathophysiology  2021,28(4),489-495","journal-title":"Pathophysiology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/HYPERTENSIONAHA.111.181990","volume":"59","author":"Salvi E.","year":"2012","unstructured":"Salvi E.; Kutalik Z.; Glorioso N.; Benaglio P.; Frau F.; Kuznetsova T.; Arima H.; Hoggart C.; Tichet J.; Nikitin Y.P.; Conti C.; Seidlerova J.; Tikhonoff V.; Stolarz-Skrzypek K.; Johnson T.; Devos N.; Zagato L.; Guarrera S.; Zaninello R.; Calabria A.; Stancanelli B.; Troffa C.; Thijs L.; Rizzi F.; Simonova G.; Lupoli S.; Argiolas G.; Braga D.; D\u2019Alessio M.C.; Ortu M.F.; Ricceri F.; Mercurio M.; Descombes P.; Marconi M.; Chalmers J.; Harrap S.; Filipovsky J.; Bochud M.; Iacoviello L.; Ellis J.; Stanton A.V.; Laan M.; Padmanabhan S.; Dominiczak A.F.; Samani N.J.; Melander O.; Jeunemaitre X.; Manunta P.; Shabo A.; Vineis P.; Cappuccio F.P.; Caulfield M.J.; Matullo G.; Rivolta C.; Munroe P.B.; Barlassina C.; Staessen J.A.; Beckmann J.S.; Cusi D.; Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension  2012,59(2),248-255","journal-title":"Hypertension"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/01.HYP.15.5.493","volume":"15","author":"Shichiri M.","year":"1990","unstructured":"Shichiri M.; Hirata Y.; Ando K.; Emori T.; Ohta K.; Kimoto S.; Ogura M.; Inoue A.; Marumo F.; Plasma endothelin levels in hypertension and chronic renal failure. Hypertension  1990,15(5),493-496","journal-title":"Hypertension"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"Stewart D.J.","year":"1991","unstructured":"Stewart D.J.; Levy R.D.; Cernacek P.; Langleben D.; Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med  1991,114(6),464-469","journal-title":"Ann Intern Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0003-4975(93)91018-I","volume":"55","author":"Chang H.","year":"1993","unstructured":"Chang H.; Wu G.J.; Wang S.M.; Hung C.R.; Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg  1993,55(2),450-458","journal-title":"Ann Thorac Surg"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1253\/circj.71.367","volume":"71","author":"Hiramoto Y.","year":"2007","unstructured":"Hiramoto Y.; Shioyama W.; Kuroda T.; Masaki M.; Sugiyama S.; Okamoto K.; Hirota H.; Fujio Y.; Hori M.; Yamauchi-Takihara K.; Effect of bosentan on plasma endothelin-1 concentration in patients with pulmonary arterial hypertension. Circ J  2007,71(3),367-369","journal-title":"Circ J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/01.CIR.84.6.2280","volume":"84","author":"Yoshibayashi M.","year":"1991","unstructured":"Yoshibayashi M.; Nishioka K.; Nakao K.; Saito Y.; Matsumura M.; Ueda T.; Temma S.; Shirakami G.; Imura H.; Mikawa H.; Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation  1991,84(6),2280-2285","journal-title":"Circulation"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJM199110033251404","volume":"325","author":"Lerman A.","year":"1991","unstructured":"Lerman A.; Edwards B.S.; Hallett J.W.; Heublein D.M.; Sandberg S.M.; Burnett J.C.; Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med  1991,325(14),997-1001","journal-title":"N Engl J Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1291\/hypres.24.663","volume":"24","author":"Minami S.","year":"2001","unstructured":"Minami S.; Yamano S.; Yamamoto Y.; Sasaki R.; Nakashima T.; Takaoka M.; Hashimoto T.; Associations of plasma endothelin concentration with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension. Hypertens Res  2001,24(6),663-670","journal-title":"Hypertens Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1510\/icvts.2009.227967","volume":"10","author":"de Haro Miralles J.","year":"2010","unstructured":"de Haro Miralles J.; G\u00f3nzalez A.F.; Varela Casariego C.; Garc\u00eda F.A.; Onset of peripheral arterial disease: Role of endothelin in endothelial dysfunction. Interact Cardiovasc Thorac Surg  2010,10(5),760-765","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02576230","volume":"193","author":"Arendt R.M.","year":"1993","unstructured":"Arendt R.M.; Wilbert-Lampen U.; Heucke L.; Schmoeckel M.; S\u00fchler K.; Richter W.O.; Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Res Exp Med  1993,193(1),225-230","journal-title":"Res Exp Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00380-020-01767-x","volume":"36","author":"Naya M.","year":"2021","unstructured":"Naya M.; Aikawa T.; Manabe O.; Obara M.; Koyanagawa K.; Katoh C.; Tamaki N.; Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease. Heart Vessels  2021,36(7),917-923","journal-title":"Heart Vessels"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/08860220600778944","volume":"28","author":"Drakopoulos A.","year":"2006","unstructured":"Drakopoulos A.; Goumenos D.S.; Vlachojannis J.G.; Tsakas S.; Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies. Ren Fail  2006,28(6),461-467","journal-title":"Ren Fail"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"F1173","DOI":"10.1152\/ajprenal.00040.2019","volume":"316","author":"Dolinina J.","year":"2019","unstructured":"Dolinina J.; Rippe A.; \u00d6berg C.M.; Sustained, delayed, and small increments in glomerular permeability to macromolecules during systemic ET-1 infusion mediated via the ETreceptor. Am J Physiol Renal Physiol  2019,316(6),F1173-F1179","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/0024-3205(90)90286-Z","volume":"47","author":"Predel H.G.","year":"1990","unstructured":"Predel H.G.; Meyer-Lehnert H.; B\u00e4cker A.; Stelkens H.; Kramer H.J.; Plasma concentrations of endothelin in patients with abnormal vascular reactivity. Life Sci  1990,47(20),1837-1843","journal-title":"Life Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/HYPERTENSIONAHA.119.12919","volume":"74","author":"Farrah T.E.","year":"2019","unstructured":"Farrah T.E.; Anand A.; Gallacher P.J.; Kimmitt R.; Carter E.; Dear J.W.; Mills N.L.; Webb D.J.; Dhaun N.; Endothelin receptor antagonism improves lipid profiles and lowers PCSK9 (proprotein convertase subtilisin\/kexin type 9) in patients with chronic kidney disease. Hypertension  2019,74(2),323-330","journal-title":"Hypertension"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12882-024-03713-9","volume":"25","author":"Elnaga A.A.A.","year":"2024","unstructured":"Elnaga A.A.A.; Alsaied M.A.; Elettreby A.M.; Ramadan A.; Abouzid M.; Shetta R.; Al-Ajlouni Y.A.; Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: A systematic review and meta-analysis of randomized controlled trials. BMC Nephrol  2024,25(1),316","journal-title":"BMC Nephrol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.CIR.85.4.1374","volume":"85","author":"McMurray J.J.","year":"1992","unstructured":"McMurray J.J.; Ray S.G.; Abdullah I.; Dargie H.J.; Morton J.J.; Plasma endothelin in chronic heart failure. Circulation  1992,85(4),1374-1379","journal-title":"Circulation"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"H1141","DOI":"10.1152\/ajpheart.00239.2001","volume":"286","author":"Parker J.D.","year":"2004","unstructured":"Parker J.D.; Thiessen J.J.; Increased endothelin-1 production in patients with chronic heart failure. Am J Physiol Heart Circ Physiol  2004,286(3),H1141-H1145","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e36815","DOI":"10.1371\/journal.pone.0036815","volume":"7","author":"Sikkeland L.I.B.","year":"2012","unstructured":"Sikkeland L.I.B.; Dahl C.P.; Ueland T.; Andreassen A.K.; Gude E.; Edvardsen T.; Holm T.; Yndestad A.; Gullestad L.; Kongerud J.; Aukrust P.; \u00d8ie E.; Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure. PLoS One  2012,7(5),e36815","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0025-6196(12)60795-2","volume":"67","author":"Rodeheffer R.J.","year":"1992","unstructured":"Rodeheffer R.J.; Lerman A.; Heublein D.M.; Burnett J.C.; Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc  1992,67(8),719-724","journal-title":"Mayo Clin Proc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.89.4.1580","volume":"89","author":"Wei C.M.","year":"1994","unstructured":"Wei C.M.; Lerman A.; Rodeheffer R.J.; McGregor C.G.; Brandt R.R.; Wright S.; Heublein D.M.; Kao P.C.; Edwards W.D.; Burnett J.C.; Endothelin in human congestive heart failure. Circulation  1994,89(4),1580-1586","journal-title":"Circulation"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1071-9164(96)80025-X","volume":"2","author":"Galatius-Jensen S.","year":"1996","unstructured":"Galatius-Jensen S.; Wroblewski H.; Emmeluth C.; Bie P.; Hauns\u00f8 S.; Kastrup J.; Plasma endothelin in congestive heart failure: A predictor of cardiac death? J Card Fail  1996,2(2),71-76","journal-title":"J Card Fail"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1054\/jcaf.2003.39","volume":"9","author":"Kinugawa T.","year":"2003","unstructured":"Kinugawa T.; Kato M.; Ogino K.; Osaki S.; Igawa O.; Hisatome I.; Shigemasa C.; Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. J Card Fail  2003,9(4),318-324","journal-title":"J Card Fail"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0735-1097(10)80214-1","volume":"18","author":"Stewart D.J.","year":"1991","unstructured":"Stewart D.J.; Kubac G.; Costello K.B.; Cernacek P.; Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol  1991,18(1),38-43","journal-title":"J Am Coll Cardiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1378\/chest.127.5.1474","volume":"127","author":"Khan I.A.","year":"2005","unstructured":"Khan I.A.; Role of endothelin-1 in acute myocardial infarction. Chest  2005,127(5),1474-1476","journal-title":"Chest"},{"key":"ref=52","first-page":"161","volume":"48","author":"Antonopoulos A.","year":"2007","unstructured":"Antonopoulos A.; Kyriacou C.; Kazianis G.; Significance of endothelin-1 in myocardial infarction. Hellenic J Cardiol  2007,48(3),161-164","journal-title":"Hellenic J Cardiol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1378\/chest.127.5.1491","volume":"127","author":"Yip H.K.","year":"2005","unstructured":"Yip H.K.; Wu C.J.; Chang H.W.; Yang C.H.; Yu T.H.; Chen Y.H.; Hang C.L.; Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest  2005,127(5),1491-1497","journal-title":"Chest"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/CRD.0b013e318283f65a","volume":"21","author":"Kolettis T.M.","year":"2013","unstructured":"Kolettis T.M.; Barton M.; Langleben D.; Matsumura Y.; Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev  2013,21(5),249-256","journal-title":"Cardiol Rev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.STR.23.7.1014","volume":"23","author":"Ziv I.","year":"1992","unstructured":"Ziv I.; Fleminger G.; Djaldetti R.; Achiron A.; Melamed E.; Sokolovsky M.; Increased plasma endothelin-1 in acute ischemic stroke. Stroke  1992,23(7),1014-1016","journal-title":"Stroke"},{"key":"ref=56","first-page":"329","volume":"48","author":"Sapira V.","year":"2010","unstructured":"Sapira V.; Cojocaru I.M.; Lilios G.; Grigorian M.; Cojocaru M.; Study of endothelin-1 in acute ischemic stroke. Rom J Intern Med  2010,48(4),329-332","journal-title":"Rom J Intern Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/jscd.2000.7231","volume":"9","author":"Alio\u011flu Z.","year":"2000","unstructured":"Alio\u011flu Z.; B\u00fclb\u00fcl I.; \u00d6rem A.; \u00d6zmeno\u011flu M.; Vanizor B.; Boz C.; Increased plasma endothelin-1 levels in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis  2000,9(4),176-180","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","volume":"20","author":"Nusrat S.","year":"2014","unstructured":"Nusrat S.; Khan M.S.; Fazili J.; Madhoun M.F.; Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol  2014,20(18),5442-5460","journal-title":"World J Gastroenterol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hep.1840160117","volume":"16","author":"Uchihara M.","year":"1992","unstructured":"Uchihara M.; Izumi N.; Sato C.; Marumo F.; Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology  1992,16(1),95-99","journal-title":"Hepatology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/BF02806347","volume":"28","author":"Uchida Y.","year":"1993","unstructured":"Uchida Y.; Watanabe M.; Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis. Gastroenterol Jpn  1993,28(5),666-672","journal-title":"Gastroenterol Jpn"},{"key":"ref=61","first-page":"735","volume":"21","author":"Gerbes A.L.","year":"1995","unstructured":"Gerbes A.L.; M\u00f8ller S.; G\u00fclberg V.; Henriksen J.H.; Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: Role of splanchnic and renal passage and liver function. Hepatology  1995,21(3),735-739","journal-title":"Hepatology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0168-8278(96)80025-0","volume":"24","author":"Bernardi M.","year":"1996","unstructured":"Bernardi M.; G\u00fclberg V.; Colantoni A.; Trevisani F.; Gasbarrini A.; Grebes A.L.; Plasma endothelin-1 and -3 in cirrhosis: Relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol  1996,24(2),161-168","journal-title":"J Hepatol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/0016-5085(93)90360-O","volume":"104","author":"Asbert M.","year":"1993","unstructured":"Asbert M.; Gin\u00e8s A.; Gin\u00e8s P.; Jim\u00e9nez W.; Cl\u00e0ria J.; Sal\u00f3 J.; Arroyo V.; Rivera F.; Rod\u00e9s J.; Circulating levels of endothelin in cirrhosis. Gastroenterology  1993,104(5),1485-1491","journal-title":"Gastroenterology"},{"key":"ref=64","first-page":"361","volume":"22","author":"Milnerowicz S.","year":"2013","unstructured":"Milnerowicz S.; Milnerowicz H.; Nabzdyk S.; Jab\u0142onowska M.; Grabowski K.; Tabo\u0142a R.; Plasma endothelin-1 levels in pancreatic inflammations. Adv Clin Exp Med  2013,22(3),361-368","journal-title":"Adv Clin Exp Med"},{"key":"ref=65","first-page":"290","volume":"5","author":"Bennett J.","year":"2006","unstructured":"Bennett J.; Cooper D.; Balakrishnan A.; Rhodes M.; Lewis M.; Is there a role for serum endothelin in predicting the severity of acute pancreatitis? Hepatobiliary Pancreat Dis Int  2006,5(2),290-293","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref=66","first-page":"140","volume":"1","author":"Zeng X.H.","year":"2002","unstructured":"Zeng X.H.; Zhu S.Q.; Zhang X.M.; Luo W.J.; Li S.W.; Plasma endothelin and nitric oxide levels in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int  2002,1(1),140-142","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00041327-200103000-00011","volume":"21","author":"Haufschild T.","year":"2001","unstructured":"Haufschild T.; Shaw S.G.; Kesselring J.; Flammer J.; Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol  2001,21(1),37-38","journal-title":"J Neuroophthalmol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard.54.9.730","volume":"54","author":"Morelli S.","year":"1995","unstructured":"Morelli S.; Ferri C.; Di Francesco L.; Baldoncini R.; Carlesimo M.; Bottoni U.; Properzi G.; Santucci A.; Plasma endothelin-1 levels in patients with systemic sclerosis: Influence of pulmonary or systemic arterial hypertension. Ann Rheum Dis  1995,54(9),730-734","journal-title":"Ann Rheum Dis"},{"key":"ref=69","first-page":"266","volume":"30","author":"Letizia C.","year":"1998","unstructured":"Letizia C.; Boirivant M.; De Toma G.; Cerci S.; Subioli S.; Scuro L.; Ferrari P.; Pallone F.; Plasma levels of endothelin-1 in patients with Crohn\u2019s disease and ulcerative colitis. Ital J Gastroenterol Hepatol  1998,30(3),266-269","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"Torres J.","year":"2017","unstructured":"Torres J.; Mehandru S.; Colombel J.F.; Peyrin-Biroulet L.; Crohn\u2019s disease. Lancet  2017,389(10080),1741-1755","journal-title":"Lancet"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/ard.50.7.526-c","volume":"50","author":"Julkunen H.","year":"1991","unstructured":"Julkunen H.; Saijonmaa O.; Gr\u00f6nhagen-Riska C.; Teppo A.M.; Fyhrquist F.; Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus. Ann Rheum Dis  1991,50(7),526-527","journal-title":"Ann Rheum Dis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/art.1780340220","volume":"34","author":"Yamane K.","year":"1991","unstructured":"Yamane K.; Kashiwagi H.; Suzuki N.; Miyauchi T.; Yanagisawa M.; Goto K.; Masaki T.; Elevated plasma levels of endothelin-1 in systemic sclerosis. Arthritis Rheum  1991,34(2),243-244","journal-title":"Arthritis Rheum"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/art.1780350406","volume":"35","author":"Miyasaka N.","year":"1992","unstructured":"Miyasaka N.; Hirata Y.; Ando K.; Sato K.; Morita H.; Shichiri M.; Kanno K.; Tomita K.; Marumo F.; Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum  1992,35(4),397-400","journal-title":"Arthritis Rheum"},{"key":"ref=74","first-page":"CR616","volume":"8","author":"Pache M.","year":"2002","unstructured":"Pache M.; Schwarz H.A.; Kaiser H.J.; W\u00fcest P.; Kl\u00f6ti M.; Dubler B.; Flammer J.; Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit  2002,8(9),CR616-CR619","journal-title":"Med Sci Monit"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2340\/0001555576442443","volume":"76","author":"Zachariae H.","year":"1996","unstructured":"Zachariae H.; Heickendorff L.; Bjerring P.; Plasma endothelin in psoriasis: Possible relations to therapy and toxicity. Acta Derm Venereol  1996,76(6),442-443","journal-title":"Acta Derm Venereol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/jpm13111558","volume":"13","author":"Turgunova L.","year":"2023","unstructured":"Turgunova L.; Mekhantseva I.; Laryushina Y.; Alina A.; Bacheva I.; Zhumadilova Z.; Turmukhambetova A.; The association of endothelin-1 with early and long-term mortality in COVID-19. J Pers Med  2023,13(11),1558","journal-title":"J Pers Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.thromres.2021.11.027","volume":"209","author":"Willems L.H.","year":"2022","unstructured":"Willems L.H.; Nagy M.; ten Cate H.; Spronk H.M.H.; Groh L.A.; Leentjens J.; Janssen N.A.F.; Netea M.G.; Thijssen D.H.J.; Hannink G.; van Petersen A.S.; Warl\u00e9 M.C.; Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res  2022,209,106-114","journal-title":"Thromb Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1182182","DOI":"10.3389\/fimmu.2023.1182182","volume":"14","author":"Jacobs L.M.C.","year":"2023","unstructured":"Jacobs L.M.C.; Wintjens M.S.J.N.; Nagy M.; Willems L.; ten Cate H.; Spronk H.M.H.; van Kuijk S.M.J.; Ghossein-Doha C.; Netea M.G.; Groh L.A.; van Petersen A.S.; Warl\u00e9 M.C.; Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection. Front Immunol  2023,14,1182182","journal-title":"Front Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/09674845.2020.1868685","volume":"78","author":"Liu T.","year":"2021","unstructured":"Liu T.; Li X.; Liu D.; Liu S.; Dong M.; Increased serum CA125 II, but not CEA,CA19-9,AFP or CA72-4 in colon cancer compared to rectal cancer. Br J Biomed Sci  2021,78(4),218-220","journal-title":"Br J Biomed Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"Sproston N.R.","year":"2018","unstructured":"Sproston N.R.; Ashworth J.J.; Role of C-reactive protein at sites of inflammation and infection. Front Immunol  2018,9(9),754","journal-title":"Front Immunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ajcp\/aqz142","volume":"153","author":"Lapi\u0107 I.","year":"2020","unstructured":"Lapi\u0107 I.; Padoan A.; Bozzato D.; Plebani M.; Erythrocyte sedimentation rate and C-reactive protein in acute inflammation. Am J Clin Pathol  2020,153(1),14-29","journal-title":"Am J Clin Pathol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1237729","DOI":"10.3389\/fimmu.2023.1237729","volume":"14","author":"Rizo-T\u00e9llez S.A.","year":"2023","unstructured":"Rizo-T\u00e9llez S.A.; Sekheri M.; Filep J.G.; C-reactive protein: A target for therapy to reduce inflammation. Front Immunol  2023,14(14),1237729","journal-title":"Front Immunol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1096\/fasebj.5.12.1916094","volume":"5","author":"Rubanyi G.M.","year":"1991","unstructured":"Rubanyi G.M.; Botelho L.H.P.; Endothelins. FASEB J  1991,5(12),2713-2720","journal-title":"FASEB J"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1440-1681.1999.03013.x","volume":"26","author":"Neylon C.B.","year":"1999","unstructured":"Neylon C.B.; Vascular biology of endothelin signal transduction. Clin Exp Pharmacol Physiol  1999,26(2),149-153","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/BF00877413","volume":"8","author":"Hasdai D.","year":"1994","unstructured":"Hasdai D.; Kornowski R.; Battler A.; Endothelin and myocardial ischemia. Cardiovasc Drugs Ther  1994,8(4),589-599","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2215\/CJN.11130919","volume":"15","author":"Li P.","year":"2020","unstructured":"Li P.; Schmidt I.M.; Sabbisetti V.; Tio M.C.; Opotowsky A.R.; Waikar S.S.; Plasma endothelin-1 and risk of death and hospitalization in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol  2020,15(6),784-793","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1054-3589(08)60665-1","volume":"33","author":"Opgenorth T.J.","year":"1995","unstructured":"Opgenorth T.J.; Endothelin receptor antagonism. Adv Pharmacol  1995,33,1-65","journal-title":"Adv Pharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0140-6736(95)91504-4","volume":"346","author":"Kiowski W.","year":"1995","unstructured":"Kiowski W.; Kim J.; Oechslin E.; S\u00fctsch G.; Hunziker P.; M\u00fcller P.; Bertel O.; Schmitt R.; Jones R.; Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet  1995,346(8977),732-736","journal-title":"Lancet"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0140-6736(98)09423-9","volume":"353","author":"Benigni A.","year":"1999","unstructured":"Benigni A.; Remuzzi G.; Endothelin antagonists. Lancet  1999,353(9147),133-138","journal-title":"Lancet"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0895-7061(98)00094-6","volume":"11","author":"Demattia G.","year":"1998","unstructured":"Demattia G.; Cassonefaldetta M.; Bellini C.; Bravi M.; Laurenti O.; Baldoncini R.; Santucci A.; Ferri C.; Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am J Hypertens  1998,11(8),983-988","journal-title":"Am J Hypertens"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1517\/13543784.11.7.991","volume":"11","author":"Roux S.","year":"2002","unstructured":"Roux S.; Rubin L.J.; Bosentan: A dual endothelin receptor antagonist. Expert Opin Investig Drugs  2002,11(7),991-1002","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/DDDT.S3057","volume":"265","author":"Klinger J.","year":"2008","unstructured":"Klinger J.; Ambrisentan for the treatment of pulmonary arterial hypertension. Drug Des Devel Ther  2008,265,265","journal-title":"Drug Des Devel Ther"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000029278","volume":"65","author":"\u00c7elik G.","year":"1998","unstructured":"\u00c7elik G.; Karabiyiko\u011flu G.; Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Respiration  1998,65(4),289-294","journal-title":"Respiration"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/rr44","volume":"2","author":"Fagan K.A.","year":"2001","unstructured":"Fagan K.A.; McMurtry I.F.; Rodman D.M.; Role of endothelin-1 in lung disease. Respir Res  2001,2(2),90-101","journal-title":"Respir Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/0002-9378(91)90317-K","volume":"165","author":"Nova A.","year":"1991","unstructured":"Nova A.; Sibai B.M.; Barton J.R.; Mercer B.M.; Mitchell M.D.; Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol  1991,165(3),724-727","journal-title":"Am J Obstet Gynecol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/eye.1999.47","volume":"13","author":"Best R.M.","year":"1999","unstructured":"Best R.M.; Hayes R.; Chakravarthy U.; Archer D.B.; Hadden D.R.; Plasma levels of endothelin-1 in diabetic retinopathy in pregnancy. Eye  1999,13(2),179-182","journal-title":"Eye"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/0144361021000020321","volume":"22","author":"Khedun S.M.","year":"2002","unstructured":"Khedun S.M.; Naicker T.; Moodley J.; Endothelin-1 activity in pregnancy. J Obstet Gynaecol  2002,22(6),590-593","journal-title":"J Obstet Gynaecol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/cs0970149","volume":"97","author":"Wollesen F.","year":"1999","unstructured":"Wollesen F.; Berglund L.; Berne C.; Plasma endothelin-1 and total insulin exposure in diabetes mellitus. Clin Sci  1999,97(2),149-156","journal-title":"Clin Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0002-8703(93)90155-3","volume":"125","author":"Tomoda H.","year":"1993","unstructured":"Tomoda H.; Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J  1993,125(3),667-672","journal-title":"Am Heart J"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0300-9572(94)90003-5","volume":"27","author":"Haynes W.G.","year":"1994","unstructured":"Haynes W.G.; Wayne Hamer D.; Robertson C.E.; Webb D.J.; Plasma endothelin following cardiac arrest: Differences between survivors and non-survivors. Resuscitation  1994,27(2),117-122","journal-title":"Resuscitation"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673377544250714073536","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/245687\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673377544250714073536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:47:55Z","timestamp":1785754075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/245687\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":100,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673377544250714073536","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}